Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2019

Every FDA drug recall initiated in 2019, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,788 recalls, newest first.

Class II · Moderate risk

Lid O Creme

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-111-25 D-1502-2019
Class II · Moderate risk

Lido E.R. (Lidocaine HCL 4%)

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-115-04 D-1501-2019
Class II · Moderate risk

Dermanak original crema blanqueador

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-108-02 D-1500-2019
Class II · Moderate risk

LidoAID (Lidocaine HCL 4%)

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-114-04 D-1499-2019
Class II · Moderate risk

Double Tussin Dm

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63708-121-04 D-1498-2019
Class II · Moderate risk

Gencontuss

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 52083-650-16 D-1497-2019
Class II · Moderate risk

ARMY HEALTH Pain Reliever Gel With CURCUMIN

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. D-1496-2019
Class II · Moderate risk

ARMY HEALTH With CURCUMIN

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. D-1494-2019
Class II · Moderate risk

AbeeMed cream

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. D-1493-2019
Class II · Moderate risk

Oliver's Harvest CBD+Capsaicin 0.2% Pain Relief

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-120-04 D-1492-2019
Class II · Moderate risk

Losartan Potassium Tablets 50 mg 1000 Tablets

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Terminated Nitrosamine impurity Macleods Pharma Usa Inc NDC 33342-045-44 D-1458-2019
Class II · Moderate risk

Losartan Potassium Tablets

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Terminated Nitrosamine impurity Macleods Pharma Usa Inc NDC 33342-045-10 D-1457-2019

Recalls by year